NCT06170463View on ClinicalTrials.gov

Insulin Sensitizers Role in Control of PCOS Vicious Cycle.

PHASE1CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

April 15, 2023

Conditions
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Interventions
DRUG

Metformin Hydrochloride

Met Group Received metformin hydrochloride 500 mg tab 3 times Daily

DRUG

MI/DCI combination in 40:1 ratio

MI-group received MI/DCI combination in 40:1 ratio twice daily

DRUG

Combination of Metformin hydrochloride and MI/DCI

MM Group Received both Met and MI Groups Treatment

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV